RATIONALE: Allergic rhinitis (AR) is a common disease in children; the main pharmacotherapy includes antihistamine and intranasal steroid (INS). Patient preference and compliance of treatment are ones of the key factors that contribute to the success of AR treatment. METHODS: We conducted a cross-sectional questionnaire survey study in 250 children with AR aged between 1-18 years. The primary outcome was to study compliance and preference of treatment. The secondary outcome was to study adverse effects of pharmacotherapy. NYU Winthrop University Hospital, Mineola, NY. RATIONALE: Mandatory influenza vaccination for all hospital employees is increasingly common, and was a policy at NYU Langone Health System (NYC, Winthrop, Lutheran) in 2017. Employees applying for exemption based on prior allergic reaction underwent evaluation by an allergist. We assessed the success of mandating the vaccine and whether allergic evaluation increased vaccination rates. METHODS: Prior reaction history, skin testing, and outcomes of evaluation were reviewed from charts. Primary outcomes were total vaccination rate and outcomes of those that applied for exemption. RESULTS: A total of 39,146 of 39,558 employees (98.9%) received vaccination without evaluation. Of 39,558 employees, 419 (0.01%) applied for exemption; 73 sought exemption based on prior allergic reaction. Exemption was granted to 303 employees for other reasons. Egg-free vaccine was administered to 38/73 (52%) who reported egg allergy. The remaining 35 underwent allergy evaluation; 15 were granted exemption while 20 (57%) were vaccinated. At Winthrop, 46 employees applied for medical exemption due to allergy; 45 (97%) were ultimately vaccinated. Eight employees with reported vaccine allergy were evaluated. Four received the vaccine without testing, while four were skin tested. One patient developed a generalized rash with skin testing and was granted exemption. The other three successfully received influenza vaccine via graded challenge. Stanford University School of Medicine, Stanford, CA. RATIONALE: Previous studies report that medication allergies are rarely accurately or completely documented in the medical record; however, the barriers to documentation are unclear. The purpose of this study was to evaluate providers' attitudes towards the documentation of drug allergies. METHODS: This study consisted of two parts: (1) a patient chart review and (2) a survey of healthcare providers. In Part One, 150 patient charts were surveyed on allergy documentation. In Part Two, 67 physicians and nurses completed a survey on their allergy documentation process and their perceived barriers in documenting allergies. RESULTS: Of the patient charts with recorded medication allergies, only 56% had complete documentation including a reaction type and a description of the reaction. Sixty-three percent of survey respondents reported that they do not document or update a patient's medication allergies in the chart because they are too busy with other tasks, 24% do not document allergies because it takes too much time, 22% do not document allergies because they do not think it is as important as other clinical tasks, and 25% do not feel educated enough to update the allergy section. CONCLUSIONS: Healthcare providers prioritize other tasks above documentation of medication allergies, and many feel insufficiently equipped for this task. This contributes to incomplete documentation of allergies which may increase the risk for adverse events. Potential interventions include streamlining the documentation process and education on assessing medication allergies. Canyon Vista Medical Center, Sierra Vista, AZ, 2 UC San Diego, La Jolla, CA. RATIONALE: Several studies were designed to examine the efficacy of lactobacillus probiotics in the prevention of atopic disorders in pediatric population, which conveyed conflicting results. This review is to investigate whether lactobacillus probiotic supplementation prenatally and/or postnatally could reduce the risk of pediatric atopy. METHODS: From PUBMED database, we searched and reviewed randomized controlled trials on the preventive effect of lactobacillus on pediatric atopic disorders from 2000 to 2016. Meta-analysis for the results of studies was performed using RevMan 5.0 and the co-effect was pooled by using random-effects model of relative risk (RR) ratios. RESULTS: Ten trials published between 2000 to 2006 were included in the meta-analysis. The result showed that the preventive effect of prenatal and postnatal supplementation on pediatric atopic disorder was not significant with the RR50.76 (95% CI: 0.44, 1.30). There was no evidence of significant publication bias by inspection of the funnel plot. CONCLUSIONS: Present evidence cannot show in inconsistent terms that prenatal and postnatal lactobacillus probiotic supplementation will prevent pediatric atopic disorder. 
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